S249: SELECTIVE JAK2/IRAK1/ACVR1 INHIBITOR PACRITINIB BEFORE REDUCED‐INTENSITY CONDITIONING ALLOGENEIC STEM CELL TRANSPLANTATION IN MYELOFIBROSIS: FINAL ANALYSIS OF THE PHASE II HOVON‐134 TRIAL
Van Dijck, Ruben, VAN DER Holt, Ron, Meijer, Ellen, Devos, Timothy, Hazenberg, Mette, Van Der Poel, Marjolein, Breems, Dimitri, Deleu, Lien, Schaap, Nicolaas, Te Boekhorst, Peter André Willem
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
Increased transplant-related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell–depleted stem cell transplantation
Broers, Annoek E. C., van der Holt, Ron, van Esser, Joost W. J., Gratama, Jan-Willem, Henzen-Logmans, Sonja, Kuenen-Boumeester, Vibeke, Löwenberg, Bob, Cornelissen, Jan J.
Published in Blood (01.04.2000)
Published in Blood (01.04.2000)
Get full text
Journal Article
High-Dose Therapy in AL Amyloidosis: A Prospective Phase II Study by the Dutch-Belgian Cooperative Group (HOVON)
Hazenberg, Bouke P.C., Croockewit, Sandra, van der Holt, Ron, Zweegman, Sonja, Bos, Gerard, Vandenberghe, Peter, Sonneveld, Pieter, Cornelissen, Jan J., Vellenga, Edo, Wijermans, Pierre W., Willemze, Roelof, Van Oers, Marinus H.J., de Weerdt, Okke, Spoelstra, Fokje M., Lokhorst, Henk
Published in Blood (16.11.2008)
Published in Blood (16.11.2008)
Get full text
Journal Article
Increased transplant-related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell–depleted stem cell transplantation
Broers, Annoek E.C., van der Holt, Ron, van Esser, Joost W.J., Gratama, Jan-Willem, Henzen-Logmans, Sonja, Kuenen-Boumeester, Vibeke, Loüwenberg, Bob, Cornelissen, Jan J.
Published in Blood (01.04.2000)
Published in Blood (01.04.2000)
Get full text
Journal Article